Abstract
To screen specific antitumor drugs targeting telomerase catalytic subunit (hEST2), 12 differenthEST2 antisense oligonucleotides were designed based on hEST2 mRNA second structure and transfected into tumor cell lines by the lipofectin-mediated method. Cell growth activity was evaluated by MTT assay.hEST212 was picked out and its specificity, antitumor tree and continuous effect were analyzed. The results showed thathEST212 had promising antitumor activityin vitro, hEST2 can be used as a pratical target and an antisense drug candidate for cancer.
Similar content being viewed by others
References
Blackburn, E. H., Telomeres, Trends Biol. Sci., 1991, 16: 378.
Hastie, N. D., Dempster, M., Dunlop, M. G. et al., Telomere reduction in human colorectal cancinoma and with ageing, Nature, 1990; 346: 866.
Kim, N. W., Piatyszek, M. A., Prowse, K. R. et al., Specific association of human telomerase activity with immortal cells and cancer, Science, 1994, 266: 2011.
Piatyszek, M. A., Kim, N. W., Weinrich, S. L. et al., Detection of telomerase activity in human cells and tumors, Meth. Cell Sci., 1995, 17: 1.
Counter, C. M., Hirte, H. W., Baccetti, S. et al., Telomerase activity in human ovarian cancinoma, Proc. Natl. Acad. Sci. USA, 1994, 91: 2900.
Strahl, C., Blackburn, E. H., Effect of reverse transcriptase inhibition on telomere length and telomerase activity in two immortalized human cell lines, Mol. Cell Biol., 1996, 16: 53.
Strahl, C., Blackburn, E. H., The effects of nucleoside analogs on telomerase and telomeres in tetrahymena, Nucleic Acids Res., 1994, 22: 893.
Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L. et al., The RNA component of human telomerase, Science, 1995, 269: 1236.
Norton, J. C., Piatyszek, M. A., Wright, W. E. et al., Inhibition of human telomerase activity by peptide nucleic-acides, Nature Biotechnol., 1996, 14: 615.
Meyerson, M., Couner, C. M., Eaton, E. N. et al.,hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization, Cell, 1997, 90: 785.
Tahara, H., Yasui, W., Tahara, E. et al., Immunohistochemical detection of human telomerase catalytic component,hEST2, in human colorectal tumor and non-tumor tissue sections, Oncogene, 1999, 18: 1561.
Counter, C. M., Meyerson, M., Eaton, E. N. et al., Telomerase activity is restored in human cells by ectopic expression ofhEST2 (hEST2), the catalytic subunit of telomerase, Oncogene, 1998, 16: 1217.
Allsopp, R. C., Telomere length predicts replicative capacity of human fibroblasts, Proc. Natl. Acad. Sci. USA, 1992, 89: 10114.
Shay, J. W., Wright, W. E., Werbin, H., Defining the molecular mechanism of human cell immortalization, Biochim. Biophys. Acta, 1991, 1072: 1.
Shay, J. W., Werbin, H., Wright, W. E., Telomeres and telomerase in human leukemias, Leukemia, 1996, 10: 1255.
Allsopp, R. C., Harley, C. B., Evidence of a critical telomere length in senescent human fibroblasts, Exp. Cell Res., 1995, 219: 130.
Harley, C. B., Telomeres and aging: fact, fancy, and the future, J. NIH Res., 1995, 7: 64.
Meyerson, M., Counter, C. M., Eaton, E. N. et al.,hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cell and during immortalization, Cell, 1997, 90: 785.
Shaw, J. P., Kent, K., Bird, J. et al., Modified oligodeoxynucleotides stable to exonuclease degradation in serum, Nucleic Acids Res., 1991, 19: 747.
Stein, C. A., Cohen, J. S., Oligodeoxynucleotides as inhibitors of gene expression: A review, Cancer Res., 1988, 48: 2659.
Kondo, S., Kondo, Y., Li, G. Y. et al., Targeted therapy of human malignant glioma in a mouse model by 2–5A antisense directed against telomerase RNA, Oncogene, 1998, 16: 3320120.
Mandai, M., Kumar, R., Bcl-2 modulates telomerase activity, J. Biol. Chem., 1997, 272: 14183.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Wang, S., Lin, L., Chen, Z. et al. Effect of antisense oligonucleotides targeting telomerase catalytic subunit on tumor cell proliferationin vitro . Chin. Sci. Bull. 47, 993–997 (2002). https://doi.org/10.1007/BF02907568
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02907568